Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

2.010 +0.010 (+0.50%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	507,279
Open	2.000
Bid (Size)	2.000 (2,600)
Ask (Size)	2.020 (500)
Prev. Close	2.000
Today's Range	1.920 - 2.030
52wk Range	1.170 - 8.080
Shares Outstanding	19,996,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients ↗

September 10, 2025

BioXcel's Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use.

Via Benzinga

Performance

YTD	+18.2%	+18.2%
1 Month	-2.9%	-2.9%
3 Month	-23.0%	-23.0%
6 Month	-0.5%	-0.5%
1 Year	-66.7%	-66.7%

More News

BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗

September 10, 2025

Via Stocktwits

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗

September 02, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 27, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 27, 2025

Via Benzinga

Which stocks are experiencing notable movement on Wednesday? ↗

August 27, 2025

Via Chartmill

BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗

August 27, 2025

Via Stocktwits

BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug ↗

August 27, 2025

Via Stocktwits

BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label ↗

August 18, 2025

Via Stocktwits

BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment ↗

August 27, 2025

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

August 27, 2025

Via Chartmill

Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗

August 27, 2025

Via Benzinga

BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know ↗

August 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

August 26, 2025

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

August 19, 2025

Via Chartmill

Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!

August 18, 2025

Via AB Newswire

BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On? ↗

August 18, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

August 18, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 18, 2025

Via Benzinga

Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

August 18, 2025

Via Benzinga

BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label (This works) ↗

August 18, 2025

Via Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 15, 2025

Via Benzinga

Frequently Asked Questions

Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?

Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?

BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?

The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market

What is the current price of BioXcel Therapeutics, Inc. - Common Stock?

The current price of BioXcel Therapeutics, Inc. - Common Stock is 2.010

When was BioXcel Therapeutics, Inc. - Common Stock last traded?

The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 01/09/26 04:00 PM ET

What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?

The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 40.19M

How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?

BioXcel Therapeutics, Inc. - Common Stock has 40M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.